Daiichi Sankyo, Inc.

Description

Daiichi Sankyo, Inc. headquartered in Basking Ridge, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. and a member of the Daiichi Sankyo Group. Commercial Operations, Research & Development and several global functions operate out of Headquarters. Our team of more than 1,400 U.S. employees is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs. We currently market therapies in hypertension, thrombotic disorders, stroke risk reduction, dyslipidemia, diabetes, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group’s 2025 Vision to become a “Global Pharma Innovator with a Competitive Advantage in Oncology,” Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases.

Headquarters:
United States

Pharmaceuticals

Speciaties:

Innovation is integral to everything we do. Our medicines for cardiovascular, oncology and metabolic diseases are having a profound impact on countless lives today. Daiichi Sankyo, Inc. currently markets therapies in hypertension, thrombotic disorders, stroke risk reduction, dyslipidemia, diabetes, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. In addition, our research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases. PP-US-NP-0246 08/17

View Employees

Conor Wheatley
Senior Database Specialist at Daiichi Sankyo, Inc.
Malissa Carter
Production Manager at Daiichi Sankyo
Pietro Pancotto
Strategic Marketing Manager at Daiichi Sankyo, Inc.
Bradford Schueller, MBA
Senior Speciality Representative at Daiichi Sankyo, Inc.
Neelima R.
Associate Director at Daiichi Sankyo
Linda Nelson
Associate Director, Regulatory CMC at Daiichi Sankyo, Inc.
Koichi Tazaki
Associate Director at Daiichi Sankyo
Erin De La Cruz
Coordinator: Compliance - Communication and Reporting at Daiichi Sankyo, Inc.
Joe Fanelli, PGA
Primary Care Sales Representative at Daiichi Sankyo, Inc.
Matt Siegel
Region Business Director at Daiichi Sankyo, Inc.

Find more contacts